Editors' ChoiceImmunotherapy

Toward off-the-shelf adoptive T cell therapies

See allHide authors and affiliations

Science Translational Medicine  19 Apr 2017:
Vol. 9, Issue 386, eaan2779
DOI: 10.1126/scitranslmed.aan2779

Abstract

Artificial thymic organoids may enable more efficient engineered T cell production for immunotherapy.

View Full Text

Stay Connected to Science Translational Medicine